​

​

November 5, 2018

1. Impact of the American Thyroid Association guidelines on the Australian surgical management of papillary thyroid cancer.
   Cole-Clark D, Townend PJ, Engelsman A, Wong MS, Sywak M, Glover A, Sidhu SB.
   ANZ J Surg. 2018 Nov;88(11):1102-1103. doi: 10.1111/ans.14804. No abstract available.

2. A 2017 SURVEY OF THE CLINICAL PRACTICE PATTERNS IN THE MANAGEMENT OF RELAPSING GRAVES' DISEASE.
   Koren S, Shteinshnaider M, Or K, Cantrell D, Benbassat CA, Koren R.
   Endocr Pract. 2018 Nov 1. doi: 10.4158/EP-2018-0386. [Epub ahead of print]

3. STATISTICAL COMPARISON OF AFIRMA GSC AND AFIRMA GEC OUTCOMES IN A COMMUNITY ENDOCRINE SURGICAL PRACTICE: EARLY FINDINGS.
   Harrell RM, Eyerly-Webb SA, Golding AC, Edwards CM, Bimston DN.

4. Endocr Pract. 2018 Nov 1. doi: 10.4158/EP-2018-0395. [Epub ahead of print]

5.  

6. Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation.
   Capozza M, Chinellato I, Guarnieri V, Di Lorgi N, Accadia M, Traggiai C, Mattioli G, Di Mauro A, Laforgia N.
   BMC Pediatr. 2018 Oct 30;18(1):340. doi: 10.1186/s12887-018-1319-0.

7. Regeneration of a bioengineered thyroid using decellularized thyroid matrix
   Pan J, Li H, Fang Y, Shen Y, Zhou X, Zhu F, Zhu L, Du Y, Yu X, Wang Y, Zhou XH, Wang Y, Wu Y.
   Thyroid. 2018 Oct 30. doi: 10.1089/thy.2018.0068. [Epub ahead of print]

8. Thyroid Swelling: A Common Phenomenon in Art?
   Accorona R, Huskens I, Meulemans J, Cappelli C, Nicolai P, Lombardi D.
   Eur Thyroid J. 2018 Oct;7(5):272-278. doi: 10.1159/000488315. Epub 2018 May 3.

9. Differentiated Thyroid Cancer Outcomes After Surgery and Activity-Adjusted 131I Theragnostics.
   Avram AM, Rosculet N, Esfandiari NH, Gauger PG, Miller BS, Cohen M, Hughes DT.
   Clin Nucl Med. 2018 Oct 27. doi: 10.1097/RLU.0000000000002321. [Epub ahead of print]

10. A Systematic Review and Meta-analysis of Subsequent Malignant Neoplasm Risk after Radioactive Iodine Treatment of Thyroid Cancer.
    Yu CY, Saeed O, Goldberg AS, Farooq S, Fazelzad R, Goldstein DP, Tsang RW, Brierley J, Ezzat S, Thabane L, Goldsmith CH, Sawka AM.
    Thyroid. 2018 Oct 27. doi: 10.1089/thy.2018.0244. [Epub ahead of print]

11. Radial Fracture Due to Parathyroid Carcinoma.
    Suzuki T, Tomiie Y.
    N Engl J Med. 2018 Oct 11;379(15):e24. doi: 10.1056/NEJMicm1710426. No abstract available.

12. TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma.
    Svahn F, Paulsson JO, Stenman A, Fotouhi O, Mu N, Murtha TD, Korah R, Carling T, Bäckdahl M, Wang N, Juhlin CC, Larsson C.
    Int J Mol Med. 2018 Sep;42(3):1675-1683. doi: 10.3892/ijmm.2018.3735. Epub 2018 Jun 20.
     

October 29, 2018

1. Independent predisposing factors for subcutaneous and deep wound collection after total thyroidectomy, a prospective cohort study.
   Eweida AM, Ebeed HM, Sakr MF, Hamza Y, Gabr E, Koraitim T, Al-Wagih HF, Abo-Elwafa W, Abdel-Aziz TE, Nabawi AS.
   Ann Med Surg (Lond). 2018 Oct 14;36:10-16. doi: 10.1016/j.amsu.2018.10.015. eCollection 2018 Dec.

2. When Parathyroidectomy Should Be Indicated or Postponed in Adolescents With MEN1-Related Primary Hyperparathyroidism.
   Marini F, Giusti F, Tonelli F, Brandi ML
   Front Endocrinol (Lausanne). 2018 Oct 5;9:597. doi: 10.3389/fendo.2018.00597. eCollection 2018.

3. Preliminary Exploration of Potential Molecular Therapeutic Targets in Recurrent and Metastatic Parathyroid Carcinomas.
   Cui M, Hu Y, Bi Y, Wang W, Wang M, Zhang X, Zhang R, Wang P, Su Z, Gao X, Wang J, Li Q, Liao Q, Zhao Y.
   Int J Cancer. 2018 Oct 26. doi: 10.1002/ijc.31948. [Epub ahead of print]

4. Galectin-3 targeting in thyroid orthotopic tumors opens new ways to characterize thyroid cancer.
   De Rose F, Braeuer M, Braesch-Andersen S, Otto AM, Steiger K, Reder S, Mall S, Nekolla S, Schwaiger M, Weber WA, Bartolazzi A, D'Alessandria C.
   J Nucl Med. 2018 Oct 25. pii: jnumed.118.219105. doi: 10.2967/jnumed.118.219105. [Epub ahead of print]

5. Interinstitutional variation in predictive value of the ThyroSeq v2 genomic classifier for cytologically indeterminate thyroid nodules.
   Marcadis AR, Valderrabano P, Ho AS, Tepe J, Swartzwelder CE, Byrd S, Sacks WL, Untch BR, Shaha AR, Xu B, Lin O, Ghossein RA, Wong RJ, Marti JL, Morris LGT.
   Surgery. 2018 Oct 22. pii: S0039-6060(18)30502-6. doi: 10.1016/j.surg.2018.04.062. [Epub ahead of print]

6. Intraoperative parathyroid hormone testing in primary hyperparathyroidism surgery: time for giving up?
   Sartori PV, Saibene AM, Leopaldi E, Boniardi M, Beretta E, Colombo S, Morenghi E, Pauna J, De Pasquale L.
   Eur Arch Otorhinolaryngol. 2018 Oct 24. doi: 10.1007/s00405-018-5179-x. [Epub ahead of print]

7. Vocal Cord Palsies Missed by Transcutaneous Laryngeal Ultrasound (TLUSG): Do They Experience Worse Outcomes?
   Wong KP, Au KP, Lam S, Chang YK, Lang BHH.
   World J Surg. 2018 Oct 23. doi: 10.1007/s00268-018-4826-0. [Epub ahead of print]

8. Laparoscopic Hand Assisted Adrenalectomy for Tumours larger than 5cm.
   Buxton J, Vun SH, van Dellen D, Wadsworth R, Augustine T.
   Clin Endocrinol (Oxf). 2018 Oct 22. doi: 10.1111/cen.13883. [Epub ahead of print]

9. Surgical treatment of congenital hyperinsulinism: Results from 500 pancreatectomies in neonates and children.
   Adzick NS, De Leon DD, States LJ, Lord K, Bhatti TR, Becker SA, Stanley CA.
   J Pediatr Surg. 2018 Oct 5. pii: S0022-3468(18)30648-1. doi: 10.1016/j.jpedsurg.2018.10.030. [Epub ahead of print]

10. Longitudinal patterns of recurrence in patients with adrenocortical carcinoma.
    Glenn JA, Else T, Hughes DT, Cohen MS, Jolly S, Giordano TJ, Worden FP, Gauger PG, Hammer GD, Miller BS.
    Surgery. 2018 Oct 18. pii: S0039-6060(18)30530-0. doi: 10.1016/j.surg.2018.04.068. [Epub ahead of print]

October 23, 2018

1. UMD-MEN1 database: an overview of the 370 MEN1 variants present in 1,676 patients from the French population.
   Romanet P, Mohamed A, Giraud S, Odou MF, North MO, Pertuit M, Pasmant E, Coppin L, Guien C, Calender A, Borson-Chazot F, Béroud C, Goudet P, Barlier A.
   J Clin Endocrinol Metab. 2018 Oct 18. doi: 10.1210/jc.2018-01170. [Epub ahead of print]

2. Effects of Obesity and Gastric Bypass Surgery on Nutrient Sensors, Endocrine Cells, and Mucosal Innervation of the Mouse Colon.
   Peiris M, Aktar R, Raynel S, Hao Z, Mumphrey MB, Berthoud HR, Blackshaw LA. 
   Nutrients. 2018 Oct 17;10(10). pii: E1529. doi: 10.3390/nu10101529.

3. Thyroid ultrasonography reporting: consensus of Italian Thyroid Association (AIT), Italian Society of Endocrinology (SIE), Italian Society of Ultrasonography in Medicine and Biology (SIUMB) and Ultrasound Chapter of Italian Society of Medical Radiology (SIRM).
   Rago T, Cantisani V, Ianni F, Chiovato L, Garberoglio R, Durante C, Frasoldati A, Spiezia S, Farina R, Vallone G, Pontecorvi A, Vitti P.
   J Endocrinol Invest. 2018 Oct 16. doi: 10.1007/s40618-018-0935-8. [Epub ahead of print]

4. Bone mineral density changes after parathyroidectomy are dependent on biochemical profile
   Lee D, Walker MD, Chen HY, Chabot JA, Lee JA, Kuo JH.
   Surgery. 2018 Oct 13. pii: S0039-6060(18)30508-7. doi: 10.1016/j.surg.2018.04.065. [Epub ahead of print]

5. Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment
   El Lakis M, Giannakou A, Nockel PJ, Wiseman D, Gara SK, Patel D, Sater ZA, Kushchayeva YY, Klubo-Gwiezdzinska J, Nilubol N, Merino MJ, Kebebew E.
   Surgery. 2018 Oct 13. pii: S0039-6060(18)30509-9. doi: 10.1016/j.surg.2018.05.075. [Epub ahead of print]

6. The devil is in the details: Assessing treatment and outcomes of 6,795 patients undergoing remedial parathyroidectomy in the Collaborative Endocrine Surgery Quality Improvement Program.
   Kazaure HS, Thomas S, Scheri RP, Stang MT, Roman SA, Sosa JA.
   Surgery. 2018 Oct 13. pii: S0039-6060(18)30526-9. doi: 10.1016/j.surg.2018.03.026. [Epub ahead of print]

7. Contributions of fluorescence to endocrine surgery
   Bonnin-Pascual J, Álvarez-Segurado C, Jiménez-Segovia M, Bianchi A, Bonnin-Pascual F, Molina-Romero FX, González-Argente FX.
   Cir Esp. 2018 Oct 13. pii: S0009-739X(18)30250-1. doi: 10.1016/j.ciresp.2018.09.005. [Epub ahead of print] English, Spanish.

8. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: What is in a name?
   Lubitz C.
   Cancer Cytopathol. 2018 Oct 16. doi: 10.1002/cncy.22065. [Epub ahead of print] No abstract available.

9. Postoperative Pain Control and Opioid Usage Patterns among Patients Undergoing Thyroidectomy and Parathyroidectomy.
   Tharakan T, Jiang S, Fastenberg J, Ow TJ, Schiff B, Smith RV, Mehta V.
   Otolaryngol Head Neck Surg. 2018 Oct 16:194599818797574. doi: 10.1177/0194599818797574. [Epub ahead of print]

10. Dynamic risk stratification in papillary thyroid carcinoma measuring 1 to 4 cm.
    Lee YM, Cho JW, Hong SJ, Yoon JH.
    J Surg Oncol. 2018 Sep;118(4):636-643. doi: 10.1002/jso.25182. Epub 2018 Aug 16.

October 19, 2018

1. Transoral Robotic Thyroidectomy: Comparison of Surgical Outcomes Between the da Vinci Xi and Si.
   Kim HK, Kim HY, Chai YJ, Dionigi G, Berber E, Tufano RP.
   Surg Laparosc Endosc Percutan Tech. 2018 Oct 11. doi: 10.1097/SLE.0000000000000587. [Epub ahead of print]

2. The effects of sampling lateralization on bilateral inferior petrosal sinus sampling and desmopressin stimulation test for pediatric Cushing's disease.
   Chen S, Chen K, Lu L, Zhang X, Tong A, Pan H, Zhu H, Lu Z.
   Endocrine. 2018 Oct 11. doi: 10.1007/s12020-018-1779-x. [Epub ahead of print]

3. TERT Immunohistochemistry Is a Poor Predictor of TERT Promoter Mutations and Gene Expression in Follicular Thyroid Carcinoma.
   Paulsson JO, Olander A, Haglund F, Zedenius J, Juhlin CC.
   Endocr Pathol. 2018 Oct 10. doi: 10.1007/s12022-018-9551-6. [Epub ahead of print] No abstract available.

4. Medullary Thyroid Carcinoma: Do Ultrasonography and F-DOPA-PET-CT Influence the Initial Surgical Strategy?
   Brammen L, Niederle MB, Riss P, Scheuba C, Selberherr A, Karanikas G, Bodner G, Koperek O, Niederle B.
   Ann Surg Oncol. 2018 Oct 10. doi: 10.1245/s10434-018-6829-3. [Epub ahead of print]

5. C-cell hyperplasia in sporadic and familial medullary thyroid carcinoma.
   Yadav M, Agrawal V, Pani KC, Verma R, Jaiswal S, Mishra A, Pandey R.
   Indian J Pathol Microbiol. 2018 Oct-Dec;61(4):485-488. doi: 10.4103/IJPM.IJPM_478_17.

6. Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors.
   Gara SK, Lack J, Zhang L, Harris E, Cam M, Kebebew E.25.
   Nat Commun. 2018 Oct 9;9(1):4172. doi: 10.1038/s41467-018-06366-z.

7. The effect of surgery on fat mass, lipid and glucose metabolism in mild primary hyperparathyroidism
   Godang K, Lundstam K, Mollerup C, Fougner F, Pernow Y, Nordenström J, Rosén T, Jansson S, Hellström M, Bollerslev J, Heck A;
   The SIPH Study Group. Endocr Connect. 2018 Aug 1;7(8):941-948. doi: 10.1530/EC-18-0259.

8. Ultrasound Elastography is a Useful Adjunct to Conventional Ultrasonography and Needle Aspiration in Preoperative Prediction of Malignancy in Thyroid Nodules: A Northern India Perspective
   Garg M, Khandelwal D, Aggarwal V, Raja KB, Kalra S, Agarwal B, Dutta D.
   Indian J Endocrinol Metab. 2018 Sep-Oct;22(5):589-596. doi: 10.4103/ijem.IJEM_634_17.

9. International neuromonitoring study group guidelines 2018: Part II: Optimal recurrent laryngeal nerve management for invasive thyroid cancer-incorporation of surgical, laryngeal, and neural electrophysiologic data.
   Wu CW, Dionigi G, Barczynski M, Chiang FY, Dralle H, Schneider R, Al-Quaryshi Z, Angelos P, Brauckhoff K, Brooks JA, Cernea CR, Chaplin J, Chen AY, Davies L, Diercks GR, Duh QY, Fundakowski C, Goretzki PE, Hales NW, Hartl D, Kamani D, Kandil E, Kyriazidis N, Liddy W, Miyauchi A, Orloff L, Rastatter JC, Scharpf J, Serpell J, Shin JJ, Sinclair CF, Stack BC Jr, Tolley NS, Slycke SV, Snyder SK, Urken ML, Volpi E, Witterick I, Wong RJ, Woodson G, Zafereo M, Randolph GW.
   Laryngoscope. 2018 Oct 6. doi: 10.1002/lary.27360.

10. Bilateral chylothorax following reoperative central neck dissection for metastatic papillary thyroid cancer.
    Sharma AK, Sahli ZT, Mathur A.
    BMJ Case Rep. 2018 Apr 17;2018. pii: bcr-2018-224916. doi: 10.1136/bcr-2018-224916.

October 10, 2018

1. International neural monitoring study group guideline 2018 part I: Staging bilateral thyroid surgery with monitoring loss of signal.
   Schneider R, Randolph GW, Dionigi G, Wu CW, Barczynski M, Chiang FY, Al-Quaryshi Z, Angelos P, Brauckhoff K, Cernea CR, Chaplin J, Cheetham J, Davies L, Goretzki PE, Hartl D, Kamani D, Kandil E, Kyriazidis N, Liddy W, Orloff L, Scharpf J, Serpell J, Shin JJ, Sinclair CF, Singer MC, Snyder SK, Tolley NS, Van Slycke S, Volpi E, Witterick I, Wong RJ, Woodson G, Zafereo M, Dralle H.
   Laryngoscope. 2018 Oct 5. doi: 10.1002/lary.27359. [Epub ahead of print]

2. Results of Duodenopancreatic Reoperations in Multiple Endocrine Neoplasia Type 1.
   Albers MB, Manoharan J, Bollmann C, Chlosta MP, Holzer K, Bartsch DK.
   World J Surg. 2018 Oct 4. doi: 10.1007/s00268-018-4809-1. [Epub ahead of print]

3. SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for  refractory thyroid Cancer.
   Kim SY, Kim SM, Chang HJ, Kim BW, Lee YS, Park CS, Park KC, Chang HS.
   BMC Cancer. 2018 Oct 4;18(1):956. doi: 10.1186/s12885-018-4854-z.

4. Bone Health After Bariatric Surgery.
   Gagnon C, Schafer AL.
   JBMR Plus. 2018 May 1;2(3):121-133. doi: 10.1002/jbm4.10048. eCollection 2018 May. Review.

5. Can Suspicious Ultrasound Features Predict BRAFV600E Status in Papillary Thyroid Cancer?
   Khadra H, Deniwar A, Mohsin K, Monlezun D, Kandil E.
   Eur Thyroid J. 2018 Aug;7(4):205-210. doi: 10.1159/000489851. Epub 2018 Jul 5.

6. 2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism
   Kahaly GJ, Bartalena L, Hegedüs L, Leenhardt L, Poppe K, Pearce SH.
   Eur Thyroid J. 2018 Aug;7(4):167-186. doi: 10.1159/000490384. Epub 2018 Jul 25.

7. The surgical choice for unilateral thyroid carcinoma in pediatrics: Lobectomy or total thyroidectomy?
   Zong Y, Li K, Dong K, Yao W, Liu G, Xiao X.
   J Pediatr Surg. 2018 Sep 14. pii: S0022-3468(18)30533-5. doi: 10.1016/j.jpedsurg.2018.08.027. [Epub ahead of print]

8. Large Cytologically Benign Thyroid Nodules Do Not Have High Rates of Malignancy or False-Negative Rates and Clinical Observation Should be Considered: A Meta-Analysis
   Cipriani NA, White MG, Angelos P, Grogan RH.
   Thyroid. 2018 Oct 3. doi: 10.1089/thy.2018.0221. [Epub ahead of print]

9. Can We Re-Engineer the Endocrine Pancreas?
   Citro A, Ott HC.
   Curr Diab Rep. 2018 Oct 2;18(11):122. doi: 10.1007/s11892-018-1072-7. Review.

10. The magic of endocrine surgery: Our origins, our legacy, our future.
    Zeiger MA.
    Surgery. 2018 Sep 26. pii: S0039-6060(18)30538-5. doi: 10.1016/j.surg.2018.08.018. [Epub ahead of print] No abstract available.

October 2, 2018

1. Usefulness of iodine-123 whole-body scan in planning iodine-131 treatment of the differentiated thyroid carcinoma in children and adolescence.
   Villani MF, Grossi A, Cassano B, Pizzoferro M, Ubertini G, Longo M, Garganese MC.
   Nucl Med Commun. 2018 Sep 26. doi: 10.1097/MNM.0000000000000922. [Epub ahead of print]

2. TEKT4 Promotes Papillary Thyroid Cancer Cell Proliferation, Colony Formation, and Metastasis through Activating PI3K/Akt Pathway.
   Zheng Z, Zhou X, Cai Y, Chen E, Zhang X, Wang O, Wang Q, Liu H.
   Endocr Pathol. 2018 Sep 25. doi: 10.1007/s12022-018-9549-0. [Epub ahead of print]

3. Current Standards and Recent Advances in Biomarkers of Major Endocrine Tumors.
   Luo Y, Zhu H, Tan T, He J.
   Front Pharmacol. 2018 Sep 10;9:963. doi: 10.3389/fphar.2018.00963. eCollection 2018. Review.

4. Should the duration of primary hyperparathyroidism impact guidelines for evaluation and treatment?
   Randle RW, Lee CY.
   Surgery. 2018 Sep 22. pii: S0039-6060(18)30541-5. doi: 10.1016/j.surg.2018.07.044. [Epub ahead of print] No abstract available.

5. Prediction of Postoperative Vocal Fold Function After Intraoperative Recovery of Loss of Signal.
   Schneider R, Randolph G, Dionigi G, Barczynski M, Chiang FY, Wu CW, Musholt T, Uludag M, Makay Ö, Sezer A, Teksöz S, Weber T, Sekulla C, Lorenz K, Özdemir M, Machens A, Dralle H. Laryngoscope.
   2018 Sep 24. doi: 10.1002/lary.27327. [Epub ahead of print]

6. Thyroid disorders induced by checkpoint inhibitors.
   Ferrari SM, Fallahi P, Galetta F, Citi E, Benvenga S, Antonelli A.
   Rev Endocr Metab Disord. 2018 Sep 21. doi: 10.1007/s11154-018-9463-2. [Epub ahead of print] Review.

7. Surgical management of large adrenal tumors: impact of different laparoscopic approaches and resection methods on perioperative and long-term outcomes.
   Chen W, Liang Y, Lin W, Fu GQ, Ma ZW.
   BMC Urol. 2018 May 8;18(1):31. doi: 10.1186/s12894-018-0349-0.

8. Are Cushing's disease patients curable?
   Bertagna X.
   Ann Endocrinol (Paris). 2018 Jun;79(3):153-156. doi: 10.1016/j.ando.2018.03.012. Epub 2018 Apr 9. Review.

9. Efficacy and safety of metyrosine in pheochromocytoma/paraganglioma: a multi-center trial in Japan.
   Naruse M, Satoh F, Tanabe A, Okamoto T, Ichihara A, Tsuiki M, Katabami T, Nomura M, Tanaka T, Matsuda T, Imai T, Yamada M, Harada T, Kawata N, Takekoshi K.
   Endocr J. 2018 Mar 28;65(3):359-371. doi: 10.1507/endocrj.EJ17-0276. Epub 2018 Jan 20.

10. Thirty-day readmissions following parathyroidectomy: Evidence from the National Readmissions Database, 2013-2014.
    Kravietz AM, Buicko JL, Parreco JP, Lopez MA, Kozol RA.
    Am J Otolaryngol. 2018 Mar - Apr;39(2):82-87. doi: 10.1016/j.amjoto.2018.01.006. Epub 2018 Jan 10.

September 18, 2018

1. Limits of continuous neural monitoring in thyroid surgery.  
   Sun H, Wu CW, Catalfamo A, Fabiano V, Dionigi G.
   Updates Surg. 2018 Sep 11. doi: 10.1007/s13304-018-0593-6. [Epub ahead of print]

2. Coexistence of <i>TERT</i> Promoter Mutations and the <i>BRAF</i> V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients.
   Rusinek D, Pfeifer A, Krajewska J, Oczko-Wojciechowska M, Handkiewicz-Junak D, Pawlaczek A, Zebracka-Gala J, Kowalska M, Cyplinska R, Zembala-Nozynska E, Chekan M, Chmielik E, Kropinska A, Lamch R, Jurecka-Lubieniecka B, Jarzab B, Czarniecka A.
   Int J Mol Sci. 2018 Sep 6;19(9). pii: E2647. doi: 10.3390/ijms19092647.

3. Parathyroid Carcinoma Causing Mild Hyperparathyroidism in Neurofibromatosis Type 1: A Case Report and Systematic Review.
   Triggiani V, Castellana M, Basile P, Renzulli G, Giagulli VA.
   Endocr Metab Immune Disord Drug Targets. 2018 Sep 10. doi: 10.2174/1871530318666180910123316. [Epub ahead of print]

4. Intraoperative Neuromonitoring During Thyroid Surgery: The Effect of Surgical Positioning.
   Crowther JE, Ali DB, Bamford J, Kang SW, Kandil E.
   Surg Innov. 2018 Sep 10:1553350618799786. doi: 10.1177/1553350618799786. [Epub ahead of print]

5. Association Between Age and Patient-Reported Changes in Voice and Swallowing After Thyroidectomy.
   Sahli Z, Canner JK, Najjar O, Schneider EB, Prescott JD, Russell JO, Tufano RP, Zeiger MA, Mathur A.
   Laryngoscope. 2018 Sep 7. doi: 10.1002/lary.27297. [Epub ahead of print]

6. CALCITONIN SECRETORY INDEX AND UNSUSPECTED NODAL DISEASE IN MEDULLARY THYROID CARCINOMA.
   Filimon S, Payne RJ, Black MJ, Hier MP, Mlynarek AM, Forest VI, Tamilia M.
   Endocr Pract. 2018 May;24(5):460-467. doi: 10.4158/EP-2017-0236.

7. Analysis of postoperative biochemical values and clinical outcomes after adrenalectomy for primary aldosteronism.
   Swearingen AJ, Kahramangil B, Monteiro R, Krishnamurthy V, Jin J, Shin J, Siperstein A, Berber
   E. Surgery. 2018 Apr;163(4):807-810. doi: 10.1016/j.surg.2017.10.045. Epub 2017 Dec 15.

8. Subtyping of primary aldosteronism with adrenal vein sampling: Hormone- and side-specific effects of cosyntropin and metoclopramide.  
   Rossitto G, Maiolino G, Lenzini L, Bisogni V, Seccia TM, Cesari M, Iacobone M, Rossi GP.
   Surgery. 2018 Apr;163(4):789-795. doi: 10.1016/j.surg.2017.09.032. Epub 2017 Dec 1.

9. Primary aldosteronism: making sense of partial data sets from failed adrenal venous sampling-suppression of adrenal aldosterone production can be used in clinical decision making.
   Strajina V, Al-Hilli Z, Andrews JC, Bancos I, Thompson GB, Farley DR, Lyden ML, Dy BM, Young WF, McKenzie TJ.
   Surgery. 2018 Apr;163(4):801-806. doi: 10.1016/j.surg.2017.10.012. Epub 2017 Nov 22.

10. Long-term voice quality outcomes after total thyroidectomy: a prospective multicenter study.
    Borel F, Christou N, Marret O, Mathonnet M, Caillard C, Bannani S, Drui D, Espitalier F, Blanchard C, Mirallié E.
    Surgery. 2018 Apr;163(4):796-800. doi: 10.1016/j.surg.2017.09.023. Epub 2017 Nov 20.

11. β Cell Replacement Therapy: The Next 10 Years.
    Schuetz C, Anazawa T, Cross SE, Labriola L, Meier RPH, Redfield RR 3rd, Scholz H, Stock PG, Zammit NW;
    IPITA YIC Young Investigator Committee. Transplantation. 2018 Feb;102(2):215-229. doi: 10.1097/TP.0000000000001937. Review.

September 13, 2018

1. Staged Thyroidectomy: A Single Institution Perspective.
   Wu CW, Sun H, Zhang G, Kim HY, Catalfamo A, Portinari M, Carcoforo P, Randolph GW, Chai YJ, Dionigi G.
   Laryngoscope Investig Otolaryngol. 2018 Aug 9;3(4):326-332. doi: 10.1002/lio2.171. eCollection 2018 Aug.

2. Negative Sestamibi Scans Predict Lower Likelihood of Surgical Referral in Patients with Primary Hyperparathyroidism. 
   Lloyd JQ, Holcombe JM, Rackley AA, Tanner RM,
   Heath Giles W. Am Surg. 2018 Aug 1;84(8):1264-1268.

3. Graves' disease in children.
   Léger J, Oliver I, Rodrigue D, Lambert AS, Coutant R.
   Ann Endocrinol (Paris). 2018 Aug 16. pii: S0003-4266(18)31214-9. doi: 10.1016/j.ando.2018.08.001. [Epub ahead of print]

4. Hemostatic agent use in thyroid surgery: a meta-analysis.
   Khadra H, Bakeer M, Hauch A, Hu T, Kandil E.
   Gland Surg. 2018 Aug;7(Suppl 1):S34-S41. doi: 10.21037/gs.2018.03.02.

5. Intraoperative intermittent neuromonitoring of inferior laryngeal nerve and staged thyroidectomy: our experience.
   Cavicchi O, Burgio L, Cioccoloni E, Piccin O, Macrì G, Schiavon P, Dionigi G.
   Endocrine. 2018 Sep 1. doi: 10.1007/s12020-018-1739-5.

6. Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin Analogs.
   Kiesewetter B, Duan H, Lamm W, Haug A, Riss P, Selberherr A, Scheuba C, Raderer M.
   Oncologist. 2018 Aug 31. pii: theoncologist.2018-0191.doi:10.1634/the oncologist.2018-0191. [Epub ahead of print]

7. Adrenal incidentaloma follow-up is influenced by patient, radiologic, and medical provider factors: A review of 804 cases.
   Maher DI, Williams E, Grodski S, Serpell JW, Lee JC.
   Surgery. 2018 Aug 28. pii: S0039-6060(18)30456-2. doi: 10.1016/j.surg.2018.07.011. [Epub ahead of print]

8. A Prospective Comparative Study on Improvement of Hyperthyroid Cardiovascular Dysfunction in Patients Undergoing Total Thyroidectomy Versus Medical Management.  
   Muthukumar S, Ravikumar K, Dhalapathy S, Gomathy T, Umadevi S, Maruthupandian D.
   World J Surg. 2018 May;42(5):1408-1414. doi: 10.1007/s00268-018-4571-4.

9. Medullary Thyroid Carcinoma: Survival Analysis and Evaluation of Mutation-Specific Immunohistochemistry in Detection of Sporadic Disease.
   Jayakody S, Reagh J, Bullock M, Aniss A, Clifton-Bligh R, Learoyd D, Robinson B, Delbridge L, Sidhu S, Gill AJ, Sywak M.
   World J Surg. 2018 May;42(5):1432-1439. doi: 10.1007/s00268-018-4551-8.

10. Adrenalectomy with nephrectomy, right hepatectomy and inferior vena cava thrombectomy for adrenocortical carcinoma (with video).
    Prunel F, Bonnet S, Gaujoux S, Dousset B.
    J Visc Surg. 2018 Sep;155(4):329-331. doi: 10.1016/j.jviscsurg.2018.06.005. Epub 2018 Jul 7. No abstract available.

11. Disease impacts more than age on operative morbidity in children with Graves' disease after total thyroidectomy.
    Machens A, Elwerr M, Schneider R, Lorenz K, Dralle H.
    Surgery. 2018 Aug 30. pii: S0039-6060(18)30472-0. doi: 10.1016/j.surg.2018.07.021.

September 5, 2018

1. Translational applications of microRNAs in cancer, and therapeutic implications.
   Kwok GT, Zhao JT, Weiss J, Mugridge N, Brahmbhatt H, MacDiarmid JA, Robinson BG, Sidhu SB.
   Noncoding RNA Res. 2017 Dec 20;2(3-4):143-150. doi: 10.1016/j.ncrna.2017.12.002. eCollection 2017 Sep. Review.

2. The effects of radioactive iodine therapy on ovarian reserve: A prospective pilot study.                                                                         
   Evranos B, Faki S, Polat SB, Bestepe N, Ünlü Ersoy R, Cakir B.
   Thyroid. 2018 Aug 29. doi: 10.1089/thy.2018.0129. [Epub ahead of print]

3. Short Stay Thyroid Surgery: Can We Replicate the Same in Low Resource Setting?
   Bansal N, Yadav SK, Mishra SK, Kishore K, Mishra A, Chand G, Agarwal G, Agarwal A, Verma AK.
   J Thyroid Res. 2018 Aug 5;2018:4910961. doi: 10.1155/2018/4910961. eCollection 2018.

4. Perioperative complications of adrenalectomy - 12 years of experience from a single center/teaching hospital and literature review.
   Aporowicz M, Domosławski P, Czopnik P, Sutkowski K, Kaliszewski K.
   Arch Med Sci. 2018 Aug;14(5):1010-1019. doi: 10.5114/aoms.2018.77257. Epub 2018 Jul 20.

5. Mutational Profile of Papillary Thyroid Carcinoma in an Endemic Goiter Region of North India.
   George N, Agarwal A, Kumari N, Agarwal S, Krisnani N, Gupta SK.
   Indian J Endocrinol Metab. 2018 Jul-Aug;22(4):505-510. doi: 10.4103/ijem.IJEM_441_17.

6. Decision making for the central compartment in differentiated thyroid cancer.
   Gonçalves Filho J, Zafereo ME, Ahmad FI, Nixon IJ, Shaha AR, Vander Poorten V, Sanabria A, Hefetz AK, Robbins KT, Kamani D, Randolph GW, Coca-Pelaz A, Simo R, Rinaldo A, Angelos P, Ferlito A, Kowalski LP.
   Eur J Surg Oncol. 2018 Aug 13. pii: S0748-7983(18)31274-5. doi: 10.1016/j.ejso.2018.08.005. [Epub ahead of print] Review.

7. Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China.
   Du L, Wang Y, Sun X, Li H, Geng X, Ge M, Zhu Y.
   BMC Cancer. 2018 Mar 15;18(1):291. doi: 10.1186/s12885-018-4081-7.

8. Does hyperthyroidism worsen prognosis of thyroid carcinoma? A retrospective analysis on 2820 consecutive thyroidectomies.
   Medas F, Erdas E, Canu GL, Longheu A, Pisano G, Tuveri M, Calò PG.
   J Otolaryngol Head Neck Surg. 2018 Jan 22;47(1):6. doi: 10.1186/s40463-018-0254-2. Review.

9. Undiagnosed Primary Hyperparathyroidism and Recurrent Miscarriage: The First Prospective Pilot Study.
   DiMarco A, Christakis I, Constantinides V, Regan L, Palazzo FF.
   World J Surg. 2018 Mar;42(3):639-645. doi: 10.1007/s00268-017-4395-7.

10. Recovery of Voice After Reconstruction of the Recurrent Laryngeal Nerve and Adjuvant Nimodipine.
    Mattsson P, Frostell A, Björck G, Persson JKE, Hakim R, Zedenius J, Svensson M.
    World J Surg. 2018 Mar;42(3):632-638. doi: 10.1007/s00268-017-4235-9.

August 29, 2018

1. Factors Predicting Thyroid Malignancy in Fine Needle Aspiration Biopsy Specimens Classified as Atypia of Uncertain Significance/Follicular Lesion of Uncertain Significance.
   Brown C, Mangano W, Thompson S, Richmond B.
   Am Surg. 2018 Jul 1;84(7):1207-1213.

2. Routine thyroglobulin, neck ultrasound and physical examination in the routine follow up of patients with differentiated thyroid cancer-Where is the evidence?
   Gray JL, Singh G, Uttley L, Balasubramanian SP.
   Endocrine. 2018 Aug 20. doi: 10.1007/s12020-018-1720-3. [Epub ahead of print] Review.

3. Psychological adjustment, quality of life, and self-perceptions of reproductive health in males with congenital adrenal hyperplasia: a systematic review.
   Daae E, Feragen KB, Nermoen I, Falhammar H.
   Endocrine. 2018 Aug 20. doi: 10.1007/s12020-018-1723-0. [Epub ahead of print] Review.

4. SSTR2A expression in medullary thyroid carcinoma is correlated with longer survival.
   De Vries LH, Lodewijk L, Willems SM, Dreijerink KMA, de Keizer B, van Diest PJ, Schepers A, Bonenkamp HJ, van Engen-van Grunsven IACH, Kruijff S, van Hemel BM, Links TP, Nieveen van Dijkum EJM, van Eeden S, Valk GD, Borel Rinkes IHM, Vriens MR. 
   Endocrine. 2018 Aug 20. doi: 10.1007/s12020-018-1706-1. [Epub ahead of print]

5. Primary pigmented nodular adrenocortical disease (PPNAD) as an underlying cause of symptoms in a patient presenting with hirsutism and secondary amenorrhea: case report and literature review.
   Cyranska-Chyrek E, Filipowicz D, Szczepanek-Parulska E, Nowaczyk M, Ambroziak U, Toutounchi S, Koperski Ł, Bednarczuk T, Meczekalski B, Ruchała M.
   Gynecol Endocrinol. 2018 Aug 21:1-5. doi: 10.1080/09513590.2018.1493101. [Epub ahead of print]

6. Robot-Assisted Endocrine Surgery: Indications and Drawbacks.
   Ruhle BC, Ferguson Bryan A, Grogan RH.
   J Laparoendosc Adv Surg Tech A. 2018 Aug 22. doi: 10.1089/lap.2018.0308. [Epub ahead of print]

7. Clonal Evolution Analysis of Paired Anaplastic and Well-Differentiated Thyroid Carcinomas Reveals Shared Common Ancestor.
   Dong W, Nicolson NG, Choi J, Barbieri AL, Kunstman JW, Azar SA, Knight J, Bilguvar K, Mane SM, Lifton RP, Korah R, Carling T.
   Genes Chromosomes Cancer. 2018 Aug 22. doi: 10.1002/gcc.22678. [Epub ahead of print]

8. Clinical validation of the prognostic stage groups of the eighth edition TNM staging for medullary thyroid carcinoma.
   Park SY, Cho YY, Kim HI, Choe JH, Kim JH, Kim JS, Oh YL, Hahn SY, Shin JH, Kim K, Kim SW, Chung JH, Kim TH.
   J Clin Endocrinol Metab. 2018 Aug 17. doi: 10.1210/jc.2018-01386. [Epub ahead of print]

9. Association of Radioactive Iodine Administration After Reoperation With Outcomes Among Patients With Recurrent or Persistent Papillary Thyroid Cancer.
   Hung ML, Wu JX, Li N, Livhits MJ, Yeh MW.
   JAMA Surg. 2018 Aug 15. doi: 10.1001/jamasurg.2018.2659. [Epub ahead of print]

10. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging 7th and 8th editions.
    Tam S, Boonsripitayanon M, Amit M, Fellman BM, Li Y, Busaidy N, Cabanillas M, Dadu R, Sherman SI, Waguespack SG, Williams MD, Goepfert RP, Gross ND, Perrier N, Sturgis E, Zafereo M.
    Thyroid. 2018 Aug 24. doi: 10.1089/thy.2017.0572. [Epub ahead of print]

August 23, 2018

1. Low versus high activity radioiodine remnant ablation for differentiated thyroid carcinoma with gross extrathyroidal extension invading only strap muscles.
   Park SY, Kim HI, Choi JY, Choe JH, Kim JH, Kim JS, Oh YL, Hahn SY, Shin JH, Ahn SH, Kim K, Jeong JG, Kim SW, Chung JH, Kim TH.
   Oral Oncol. 2018 Sep;84:41-45. doi: 10.1016/j.oraloncology.2018.07.002. Epub 2018 Jul 14.

2. Prospective implementation of a standardized screening protocol for deep venous thrombosis in abdominal surgical oncology patients.
   Sinnamon AJ, Tong JKC, Bailey EA, Brown C, Colbert L, Murray S, Jackson BM, Roses RE.
   J Surg Oncol. 2018 Aug 16. doi: 10.1002/jso.25151. [Epub ahead of print]

3. Clinical and prognostic role of detection timing of distant metastases in patients with differentiated thyroid cancer.
   Albano D, Panarotto MB, Durmo R, Rodella C, Bertagna F, Giubbini R.
   Endocrine. 2018 Aug 15. doi: 10.1007/s12020-018-1713-2. [Epub ahead of print]

4. Perioperative Management of Endocrine Active Adrenal Tumors.
   Schreiner F, Anand G, Beuschlein F.
   Exp Clin Endocrinol Diabetes. 2018 Aug 14. doi: 10.1055/a-0654-5251. [Epub ahead of print]

5. Endocrine-Metabolic Response in Patients Undergoing Multiple Body Contouring Surgeries After Massive Weight Loss.
   Roxo ACW, Roxo CDP, Marques RG, Rodrigues NCP, Vigna Carneiro D, Souto FMDC, Nahas FX.
   Aesthet Surg J. 2018 Aug 10. doi: 10.1093/asj/sjy195. [Epub ahead of print]

6. Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes.
   Ganly I, Makarov V, Deraje S, Dong Y, Reznik E, Seshan V, Nanjangud G, Eng S, Bose P, Kuo F, Morris LGT, Landa I, Carrillo Albornoz PB, Riaz N, Nikiforov YE, Patel K, Umbricht C, Zeiger M, Kebebew E, Sherman E, Ghossein R, Fagin JA, Chan TA.
   Cancer Cell. 2018 Aug 13;34(2):256-270.e5. doi: 10.1016/j.ccell.2018.07.002.

7. Surgical Management of Normocalcemic Primary Hyperparathyroidism and the Impact of Intraoperative Parathyroid Hormone Testing on Outcome.
   Trinh G, Rettig E, Noureldine SI, Russell JO, Agrawal N, Mathur A, Prescott JD, Zeiger MA, Tufano RP.
   Otolaryngol Head Neck Surg. 2018 Aug 14:194599818793879. doi: 10.1177/0194599818793879. [Epub ahead of print]

8. Symptom Burden in Adults with Thyroid Cancer.
   Sawka AM, Watt S, Rodin G, Ezzat S, Howell D, Tsang RW, Brierley JD, Krzyzanowska MK, Goldstein D, Li M.
   Psychooncology. 2018 Aug 13. doi: 10.1002/pon.4853. [Epub ahead of print] No abstract available.

9. Gastrinomas: Medical or Surgical Treatment.
   Norton JA, Foster DS, Ito T, Jensen RT.
   Endocrinol Metab Clin North Am. 2018 Sep;47(3):577-601. doi: 10.1016/j.ecl.2018.04.009. Review.

10. Differential expression of miRNA199b-5p as a novel biomarker for sporadic and hereditary parathyroid tumors.
    Hwang S, Jeong JJ, Kim SH, Chung YJ, Song SY, Lee YJ, Rhee Y.
    Sci Rep. 2018 Aug 13;8(1):12016. doi: 10.1038/s41598-018-30484-9.

August 17, 2018

1. Lithium-induced Symptomatic Hypercalcemia and Hyperparathyroidism in a Patient with Bipolar Affective Disorder: A Case Report and Review of Literature.
   Pamathy G, Jayarajah U, Wangmo T, Banagala ASK.
   Indian J Psychol Med. 2018 Jul-Aug;40(4):378-380. doi: 10.4103/IJPSYM.IJPSYM_305_17.

2. Papillary-Type Carcinoma of the Thyroglossal Duct Cyst: The Case for Conservative Management.
   Wood CB, Bigcas JL, Alava I, Bischoff L, Langerman A, Kim Y.
   Ann Otol Rhinol Laryngol. 2018 Aug 9:3489418791892. doi: 10.1177/0003489418791892. [Epub ahead of print]

3. Laparoscopic Transabdominal Adrenalectomy-A Procedure That Has Stood the Test of Time.
   Livhits MJ, Yeh MW.
   JAMA Surg. 2018 Aug 8. doi: 10.1001/jamasurg.2018.2674. [Epub ahead of print] No abstract available.

4. Risk Factors Associated With Perioperative Complications and Prolonged Length of Stay After Laparoscopic Adrenalectomy.
   Chen Y, Scholten A, Chomsky-Higgins K, Nwaogu I, Gosnell JE, Seib C, Shen WT, Suh I, Duh QY.
   JAMA Surg. 2018 Aug 8. doi: 10.1001/jamasurg.2018.2648. [Epub ahead of print]

5. The Impact of Uniform Capsular Dissection Technique of Total Thyroidectomy on Postoperative Complications: An Experience of More Than 1000 Total Thyroidectomies from an Endocrine Surgery Training Centre in North India.
   Chand G, Agarwal S, Mishra A, Agarwal G, Verma AK, Mishra SK, Agarwal A, Kumar A. Indian J
   Endocrinol Metab. 2018 May-Jun;22(3):362-367. doi: 10.4103/ijem.IJEM_598_17.

6. Outpatient versus inpatient thyroidectomy: A systematic review and meta-analysis.
   Lee DJ, Chin CJ, Hong CJ, Perera S, Witterick IJ.
   Head Neck. 2018 Jan;40(1):192-202. doi: 10.1002/hed.24934. Epub 2017 Nov 9. Review.

7. Management of chyle leakage after thyroidectomy, cervical lymph node dissection, in patients with thyroid cancer.
   Park I, Her N, Choe JH, Kim JS, Kim JH.
   J. Head Neck. 2018 Jan;40(1):7-15. doi: 10.1002/hed.24852. Epub 2017 Nov 9.

8. Laparoscopic Adrenalectomy in Elderly Patients.< br /> Weinandt M, Gaujoux S, Khayat A, Bertherat J, Baillard C, Dousset B.
   Surg Laparosc Endosc Percutan Tech. 2017 Dec;27(6):e132-e135. doi: 10.1097/SLE.0000000000000465.

9. The utility of ⁶⁸Ga-DOTATATE positron-emission tomography/computed tomography in the diagnosis, management, follow-up and prognosis of neuroendocrine tumors.
   Tirosh A, Kebebew E.
   Future Oncol. 2018 Jan;14(2):111-122. doi: 10.2217/fon-2017-0393. Epub 2017 Oct 26. Review.

10. Heterotopic thyroid autotransplantation: A preliminary clinical study.
    Sakr M, El-Kerm Y, Abo-Elwafa W, Mahmoud A, Fathi I.
    Head Neck. 2018 Jan;40(1):34-45. doi: 10.1002/hed.24904. Epub 2017 Oct 27.

11. THYROSEQ^®V2.0 MOLECULAR TESTING: A COST-EFFECTIVE APPROACH FOR THE EVALUATION OF INDETERMINATE THYROID NODULES.
    ivas AM, Nassar A, Zhang J, Casler JD, Chindris AM, Smallridge R, Bernet V.
    Endocr Pract. 2018 Aug 7. doi: 10.4158/EP-2018-0212. [Epub ahead of print]

12. Characterization of fluorescence patterns exhibited by different adrenal tumors: Determining the indications for indocyanine green use in adrenalectomy.
    Kahramangil B, Kose E, Berber E. 
    Surgery. 2018 Aug 4. pii: S0039-6060(18)30322-2. doi: 10.1016/j.surg.2018.06.012. [Epub ahead of print]

August 9, 2018

1. ​Adrenocortical incidentalomas and bone: from molecular insights to clinical perspectives.
   Altieri B, Muscogiuri G, Paschou SA, Vryonidou A, Della Casa S, Pontecorvi A, Fassnacht M, Ronchi CL, Newell-Price J.
   Endocrine. 2018 Aug 2. doi: 10.1007/s12020-018-1696-z. [Epub ahead of print] Review.

2. Efficacy of surgeon-performed, ultrasound-guided lymph node fine needle aspiration in patients with thyroid pathologic conditions.
   Kahramangil B, Kose E, Donmez M, Aydin H, El-Dabh D, Krishnamurthy V, Jin J, Shin JJM, Siperstein A, Berber E.
   Surgery. 2018 Jul 30. pii: S0039-6060(18)30289-7. doi: 10.1016/j.surg.2018.05.036. [Epub ahead of print]

3. AHNS Series: Do you know your guidelines? Optimizing outcomes in reoperative parathyroid surgery: Definitive multidisciplinary joint consensus guidelines of the American Head and Neck Society and the British Association of Endocrine and Thyroid Surgeons.
   Stack BC Jr, Tolley NS, Bartel TB, Bilezikian JP, Bodenner D, Camacho P, Cox JPDT, Dralle H, Jackson JE, Morris JC 3rd, Orloff LA, Palazzo F, Ridge JA, Scott-Coombes D, Steward D, Terris DJ, Thompson G, Randolph GW.
   Head Neck. 2018 Aug 2. doi: 10.1002/hed.25023. [Epub ahead of print]

4. Successful Management of Hypothyroidism in Gastric Outlet Obstruction Using Levothyroxine Rectal Enemas: A Case Report.
   Obeidat KA, Saadeh NA, As'ad A, Bakkar S.
   Am J Case Rep. 2018 Aug 1;19:903-905. doi: 10.12659/AJCR.909437.

5. Surgical options for thyroid cancer and post-surgical management.
   Doubleday A, Sippel RS.
   Expert Rev Endocrinol Metab. 2018 May;13(3):137-148. doi: 10.1080/17446651.2018.1464910. Epub 2018 Apr 20.

6. Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper.
   Pilz S, März W, Cashman KD, Kiely ME, Whiting SJ, Holick MF, Grant WB, Pludowski P, Hiligsmann M, Trummer C, Schwetz V, Lerchbaum E, Pandis M, Tomaschitz A, Grübler MR, Gaksch M, Verheyen N, Hollis BW, Rejnmark L, Karras SN, Hahn A, Bischoff-Ferrari HA, Reichrath J, Jorde R, Elmadfa I, Vieth R, Scragg R, Calvo MS, van Schoor NM, Bouillon R, Lips P, Itkonen ST, Martineau AR, Lamberg-Allardt C, Zittermann A.
   Front Endocrinol (Lausanne). 2018 Jul 17;9:373. doi: 10.3389/fendo.2018.00373. eCollection 2018. Review.

7. Spontaneous and Excellent Healing of Bilateral Brown Tumors in Mandible after Endocrinal Therapy and Subtotal Parathyroidectomy: Case Report with 4-Year Follow-Up.
   Yucesoy T, Kilic E, Dogruel F, Bayram F, Alkan A, Akcan AC, Ozturk F.
   Case Rep Dent. 2018 Jul 2;2018:8070131. doi: 10.1155/2018/8070131. eCollection 2018.

8. Challenges and controversies in the surgical management of uremic hyperparathyroidism: A systematic review.
   Cabo J, Gallagher KC, Baregamian N.
   Am J Surg. 2018 Jul 24. pii: S0002-9610(18)30090-4. doi: 10.1016/j.amjsurg.2018.07.030. [Epub ahead of print] Review.

9. Cost effectiveness of immediate biopsy versus surveillance of intermediate-suspicion thyroid nodules.
   Kuo EJ, Wu JX, Zanocco KA.
   Surgery. 2018 Jul 25. pii: S0039-6060(18)30313-1. doi: 10.1016/j.surg.2018.06.003. [Epub ahead of print]

10. Reduction of arrhythmias in primary hyperparathyroidism, by parathyroidectomy, evaluated with 24-h ECG monitoring.
    Pepe J, Cipriani C, Curione M, Biamonte F, Colangelo L, Danese V, Cecchetti V, Sonato C, Ferrone F, Cilli M, Minisola S.
    Eur J Endocrinol. 2018 Aug;179(2):117-124. doi: 10.1530/EJE-17-0948. Epub 2018 Jun 6.

11. Multi-center clinical evaluation of streptozocin-based chemotherapy for advanced pancreatic neuroendocrine tumors in Japan: focus on weekly regimens and monotherapy.
    Shibuya H, Hijioka S, Sakamoto Y, Ito T, Ueda K, Komoto I, Kobayashi N, Kudo A, Yasuda H, Miyake H, Arita J, Kiritani S, Ikeda M, Imaoka H, Ueno M, Kobayashi S, Furuta M, Nagashio Y, Murohisa G, Aoki T, Matsumoto S, Motoya M, Azemoto N, Itakura J, Horiguchi S, Yogi T, Kawagoe T, Miyaoka Y, Imamura F, Senju M, Arioka H, Hara K, Imamura M, Okusaka T.
    Cancer Chemother Pharmacol. 2018 Jul 27. doi: 10.1007/s00280-018-3656-y. [Epub ahead of print]

12. Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study.
    Antwi K, Fani M, Heye T, Nicolas G, Rottenburger C, Kaul F, Merkle E, Zech CJ, Boll D, Vogt DR, Gloor B, Christ E, Wild D.
    Eur J Nucl Med Mol Imaging. 2018 Jul 28. doi: 10.1007/s00259-018-4101-5. [Epub ahead of print]

13. Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.
    Osswald A, Deutschbein T, Berr CM, Plomer E, Mickisch A, Ritzel K, Schopohl J, Beuschlein F, Fassnacht M, Hahner S, Reincke M.
    Eur J Endocrinol. 2018 Aug;179(2):109-116. doi: 10.1530/EJE-18-0212. Epub 2018 Jun 6.

14. The Impact of Nodal Dissection on Staging in Adrenocortical Carcinoma.
    Panjwani S, Moore MD, Gray KD, Finnerty BM, Beninato T, Brunaud L, Fahey TJ 3rd, Zarnegar R.
    Ann Surg Oncol. 2017 Nov;24(12):3617-3623. doi: 10.1245/s10434-017-6064-3. Epub 2017 Sep 11.

15. Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma.
    Dhir M, Li W, Hogg ME, Bartlett DL, Carty SE, McCoy KL, Challinor SM, Yip L.
    Ann Surg Oncol. 2017 Nov;24(12):3624-3630. doi: 10.1245/s10434-017-6074-1. Epub 2017 Sep 7.

July 23, 2018

1. How I Do It: New Dissector Device Allows for Effective Operative Field in Transoral Endoscopic Thyroid Surgery Using Vestibular Approach.
   Müller V, Mogl M, Seika P, Jöns T, Sauer I, Pratschke J, Anuwong A, Zorron R.
   Sure Innov. 2018 Jul 1:1553350618785281. doi: 10.1177/1553350618785281. [Epub ahead of print]

2. Extrathyroidal Extension: Does Strap Muscle Invasion Alone Influence Recurrence and Survival in Patients with Differentiated Thyroid Cancer?
   Amit M, Boonsripitayanon M, Goepfert RP, Tam S, Busaidy NL, Cabanillas ME, Dadu R, Varghese J, Waguespack SG, Gross ND, Graham P, Williams MD, Sturgis EM, Zafereo ME.
   Ann Surg Oncol. 2018 Jul 18. doi: 10.1245/s10434-018-6563-x. [Epub ahead of print]

3. Lack of functional remission in Cushing's syndrome.
   Vermalle M, Alessandrini M, Graillon T, Paladino NC, Baumstarck K, Sebag F, Dufour H, Brue T, Castinetti F.
   Endocrine. 2018 Jul 17. doi: 10.1007/s12020-018-1664-7. [Epub ahead of print]

4. Metyrapone treatment in Cushing's syndrome: a real-life study.
   Ceccato F, Zilio M, Barbot M, Albiger N, Antonelli G, Plebani M, Watutantrige-Fernando S, Sabbadin C, Boscaro M, Scaroni C
   Endocrine. 2018 Jul 16. doi: 10.1007/s12020-018-1675-4. [Epub ahead of print]

5. Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy.
   Dominguez MLM, Iglesias SG, Arroba CM, Álvarez BL, Diaz-Guerra GM, Martinez-Pueyo JI, Herrero EF, Carranza FH.
   Endocrine. 2018 Jul 16. doi: 10.1007/s12020-018-1671-8. [Epub ahead of print]

6. Should Symptoms Be Considered an Indication for Parathyroidectomy in Primary Hyperparathyroidism?
   McDow AD, Sippel RS
   Clin Med Insights Endocrinol Diabetes. 2018 Jun 27;11:1179551418785135. doi: 10.1177/1179551418785135. eCollection 2018. Review.

7. The effect of surgery on fat mass, lipid and glucose metabolism in mild primary hyperparathyroidism.
   Godang K, Lundstam K, Mollerup C, Fougner SL, Pernow Y, Nordenström J, Rosen T, Jansson S, Hellström M, Bollerslev J, Heck A.
   Endocr Connect. 2018 Jul 16. pii: EC-18-0259. doi: 10.1530/EC-18-0259. [Epub ahead of print]

8. To admit or not to admit? Experience with outpatient thyroidectomy for Graves' disease in a high-volume tertiary care center.
   Mallick R, Asban A, Chung S, Hur J, Lindeman B, Chen H.
   Am J Surg. 2018 Jul 10. pii: S0002-9610(18)30805-5. doi: 10.1016/j.amjsurg.2018.07.002. [Epub ahead of print]

9. Morbidity in parathyroid surgery for renal disease is under reported: a comparison of outcomes with primary hyperparathyroidism.
   Nastos K, Constantinides V, Mizamtsidi M, Duncan N, Tolley N, Palazzo F.
   Ann R Coll Surg Engl. 2018 Jul;100(6):436-442. doi: 10.1308/rcsann.2018.0032.

10. Normocalcaemic primary hyperparathyroidism: a diagnostic and therapeutic algorithm.
    Gómez-Ramírez J, Mihai R.
    Langenbecks Arch Surg. 2017 Nov;402(7):1103-1108. doi: 10.1007/s00423-017-1617-2. Epub 2017 Aug 19. Review.

July 13, 2018

1. Pheochromocytoma and Paraganglioma in Neurofibromatosis type 1: frequent surgeries and cardiovascular crises indicate the need for screening.
   Petr EJ, Else T.
   Clin Diabetes Endocrinol. 2018 Jun 22;4:15. doi: 10.1186/s40842-018-0065-4. eCollection 2018

2. Improved outcomes for papillary thyroid microcarcinoma care: active surveillance and case volume.
   Freni F, Galletti B, Galletti F, Dionigi G.
   Ther Adv Endocrinol Metab. 2018 Jul;9(7):185-186. doi: 10.1177/2042018818773609. Epub 2018 May 4. No abstract available.

3. Lessons Learned From a Faulty Transoral Endoscopic Thyroidectomy Vestibular Approach.
   Zhang D, Wu CW, Inversini D, Kim HY, Anuwong A, Bacuzzi A, Dionigi G.
   Surg Laparosc Endosc Percutan Tech. 2018 Jul 2. doi: 10.1097/SLE.0000000000000555. [Epub ahead of print]

4. Do Anticoagulation Medications Increase The Risk of Hematoma in Ultrasound Guided Fine Needle Aspiration of Thyroid Lesions?
   Khadra H, Kholmatov R, Monlezun D, Kandil E.
   Endocrine. 2018 Jul 3. doi: 10.1111/cyt.12608. [Epub ahead of print]

5. Sentinel lymph node biopsy in small papillary thyroid cancer. A review on novel surgical techniques.
   Garau LM, Rubello D, Ferretti A, Boni G, Volterrani D, Manca G.
   Endocrine. 2018 Jul 2. doi: 10.1007/s12020-018-1658-5. [Epub ahead of print]

6. Perioperative serum cortisol levels in ACTH sufficient and ACTH deficient patients during transsphenoidal surgery of pituitary adenoma.
   Borg H, Siesjö P, Kahlon B, Fjalldal S, Erfurth EM.
   Endocrine. 2018 Jul 2. doi: 10.1007/s12020-018-1655-8. [Epub ahead of print]

7. Therapeutic plasmapheresis in thyrotoxic patients.
   Simsir IY, Ozdemir M, Duman S, Erdogan M, Donmez A, Ozgen AG.
   Endocrine. 2018 Jul 2. doi: 10.1007/s12020-018-1661-x. [Epub ahead of print]

8. The safety of anaesthetising biochemically hyperthyroid patients undergoing thyroidectomy-a retrospective cohort study.
   Short HL, Tamatea J, Conaglen HM, Furlonger AJ, Meyer-Rochow GY, Conaglen JV, Elston MS
   Anaesth Intensive Care. 2018 Jul;46(4):396-399.

9. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement.
   Mantovani G, Bastepe M, Monk D, de Sanctis L, Thiele S, Usardi A, Ahmed SF, Bufo R, Choplin T, De Filippo G, Devernois G, Eggermann T, Elli FM, Freson K, García Ramirez A, Germain-Lee EL, Groussin L, Hamdy N, Hanna P, Hiort O, Jüppner H, Kamenický P, Knight N, Kottler ML, Le Norcy E, Lecumberri B, Levine MA, Mäkitie O, Martin R, Martos-Moreno GÁ, Minagawa M, Murray P, Pereda A, Pignolo R, Rejnmark L, Rodado R, Rothenbuhler A, Saraff V, Shoemaker AH, Shore EM, Silve C, Turan S, Woods P, Zillikens MC, Perez de Nanclares G, Linglart A.
   Nat Rev Endocrinol. 2018 Jun 29. doi: 10.1038/s41574-018-0042-0. [Epub ahead of print] Review.

10. Preventing hypoparathyroidism after total thyroidectomy.
    Serpell JW.
    ANZ J Surg. 2018 Mar;88(3):127-128. doi: 10.1111/ans.14235. No abstract available.

July 5, 2018

1. TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma.
   Svahn F, Paulsson JO, Stenman A, Fotouhi O, Mu N, Murtha TD, Korah R, Carling T, Bäckdahl M, Wang N, Juhlin CC, Larsson C.
   Int J Mol Med. 2018 Jun 20. doi: 10.3892/ijmm.2018.3735. [Epub ahead of print]

2. Influence of neural monitoring during thyroid surgery on nerve integrity and postoperative vocal function.
   Engelsman AF, Warhurst S, Fraser S, Novakovic D, Sidhu SB.
   BJS Open. 2018 Apr 25;2(3):135-141. doi: 10.1002/bjs5.50. eCollection 2018 Jun.

3. Treatment of multiresistant prolactinomas with a combination of cabergoline and octreotide LAR.
   Sosa-Eroza E, Espinosa E, Ramírez-Rentería C, Mendoza V, Arreola R, Mercado M.
   Endocrine. 2018 Jun 11. doi: 10.1007/s12020-018-1638-9. [Epub ahead of print]

4. AHNS Series: Do you know your guidelines? AHNS Endocrine Section Consensus Statement: State-of-the-art thyroid surgical recommendations in the era of noninvasive follicular thyroid neoplasm with papillary-like nuclear features.
   Ferris RL, Nikiforov Y, Terris D, Seethala RR, Ridge JA, Angelos P, Duh QY, Wong R, Sabra MM, Fagin JA, McIver B, Bernet VJ, Harrell RM, Busaidy N, Cibas ES, Faquin WC, Sadow P, Baloch Z, Shindo M, Orloff L, Davies L, Randolph GW.
   Head Neck. 2018 Jun 26. doi: 10.1002/hed.25141. [Epub ahead of print]

5. Cushing's Disease in Older Patients: Presentation and Outcome.<
   Qiao N, Swearingen B, Tritos NA.
   Clin Endocrinol (Oxf). 2018 Jun 25. doi: 10.1111/cen.13799. [Epub ahead of print]

6. Characterization of adrenocortical tumors by ¹⁸F-FDG PET/CT: Does steroid hormone hypersecretion status modify the uptake pattern?
   Paladino NC, Guérin C, Lowery A, Attard A, Essamet W, Slotema E, Morange I, Castinetti F, Brue T, Loundou A, Taïeb D, Sebag F.
   Surg Oncol. 2018 Jun;27(2):231-235. doi: 10.1016/j.suronc.2018.04.003. Epub 2018 Apr 23.

7. How academically productive are endocrine surgeons in the United States?
   Garner EF, Valsangkar NP, Wang TN, Porterfield JR, Koniaris LG, Chen H.
   J Surg Res. 2018 Sep;229:122-126. doi: 10.1016/j.jss.2018.03.066. Epub 2018 Apr 23.

8. Retroperitoneal laparoscopic adrenalectomy with transient renal artery occlusion for large adrenal tumors (≥8 cm).
   Gong B, Ma M, Xie W, Yang X, Sun T.
   J Surg Oncol. 2018 Apr;117(5):1066-1072. doi: 10.1002/jso.25002. Epub 2018 Feb 15.

9. Skeletal fragility induced by overtreatment of adrenal insufficiency.
   Falhammar H.
   Endocrine. 2018 Feb;59(2):239-241. doi: 10.1007/s12020-017-1501-4. Epub 2017 Dec 23

10. Standing thyroidectomy in 10 horses.
    Marcatili M, Voss SJ, Pollock PJ.
    Vet Surg. 2018 Jan;47(1):86-92. doi: 10.1111/vsu.12744. Epub 2017 Nov 8.

June 26, 2018

1. Optimal combination of treatment modality to increase survival in patients with anaplastic thyroid carcinoma: A STROBE compliant retrospective study.
   Lee JH, Ahn HK, Seok JY, Lee KC, Chun YS, Chung YS, Lee YD
   Medicine (Baltimore). 2018 Jun;97(25):e11037. doi: 10.1097/MD.0000000000011037.

2. Incidence and management of postoperative hyperglycemia in patients undergoing insulinoma resection.
   Nockel P, Tirosh A, El Lakis M, Gaitanidis A, Merkel R, Patel D, Nilubol N, Sadowski SM, Cochran C, Gorden P, Kebebew E.
   Endocrine. 2018 Jun 19. doi: 10.1007/s12020-018-1633-1. [Epub ahead of print]

3. Parathyroid carcinoma in multiple endocrine neoplasm type 1 syndrome: case report and systematic literature review.
   Di Meo G, Sgaramella LI, Ferraro V, Prete FP, Gurrado A, Testini M.
   Clin Exp Med. 2018 Jun 20. doi: 10.1007/s10238-018-0512-7. [Epub ahead of print]

4. Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluation.
   Renaudin K, Smati S, Wargny M, Al Ghuzlan A, Aubert S, Leteurtre E, Patey M, Sibony M, Sturm N, Tissier F, Amar L, Bertherat J, Berthozat C, Chabre O, Do Cao C, Haissaguerre M, Pierre P, Briet C, Vezzosi D, Lifante JC, Pattou F, Mirallie E, Baudin E, Cariou B, Libe R, Drui D; for Comete-Cancer Network.
   Mod Pathol. 2018 Jun 19. doi: 10.1038/s41379-018-0077-8. [Epub ahead of print]

5. Long non-coding RNA BANCR regulates cancer stem cell markers in papillary thyroid cancer via the RAF/MEK/ERK signaling pathway.<
   Wang Y, Lin X, Fu X, Yan W, Lin F, Kuang P, Luo Y, Lin E, Hong X, Wu G.
   Oncol Rep. 2018 Jun 18. doi: 10.3892/or.2018.6502. [Epub ahead of print]

6. Re-operative Surgery for Pheochromocytoma-Paraganglioma: Analysis of 13 Cases from a Single Institution.
   Sonbare DJ, Abraham DT, Rajaratnam S, Thomas N, Manipadam MT, Pai R, Jacob PM.
   Indian J Surg. 2018 Apr;80(2):123-127. doi: 10.1007/s12262-017-1658-3. Epub 2017 Jun 5.

7. Indeterminate Thyroid Nodule: Mystery Continues Despite Recent Advances.
   Joshi A, Agrawal R.
   Indian J Endocrinol Metab. 2018 Mar-Apr;22(2):290. doi: 10.4103/ijem.IJEM_604_17. No abstract available.

8. Survival of aggressive variants of papillary thyroid carcinoma in patients under 55 years old: a SEER population-based retrospective analysis.
   Feng J, Shen F, Cai W, Gan X, Deng X, Xu B.
   Endocrine. 2018 Jun 16. doi: 10.1007/s12020-018-1644-y. [Epub ahead of print]

9. The 2017 WHO classification of pituitary adenoma: overview and comments.
   Inoshita N, Nishioka H.
   Brain Tumor Pathol. 2018 Apr;35(2):51-56. doi: 10.1007/s10014-018-0314-3. Epub 2018 Apr 23. Review.

10. Initial Clinical Investigation of [18F]Tetrafluoroborate PET/CT in Comparison to [124I]Iodine PET/CT for Imaging Thyroid Cancer.
    Samnick S, Al-Momani E, Schmid JS, Mottok A, Buck AK, Lapa C.
    Clin Nucl Med. 2018 Mar;43(3):162-167. doi: 10.1097/RLU.0000000000001977.

June 21, 2018

1. DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment.
   Conemans EB, Lodewijk L, Moelans CM, Offerhaus GJA, Pieterman CRC, Morsink FH, Dekkers OM, de Herder WW, Hermus AR, van der Horst-Schrivers ANA, Drent ML, Bisschop PH, Havekes B, Brosens LAA, Dreijerink KMA, Borel Rinkes IHM, Timmers HTM, Valk GD, Vriens MR.
   Eur J Endocrinol. 2018 Jun 14. pii: EJE-18-0195. doi: 10.1530/EJE-18-0195. [Epub ahead of print]

2. Quality of life in multiple endocrine neoplasia type 2A compared with normative and disease populations.
   Mongelli MN, Peipert BJ, Goswami S, Helenowski I, Yount SE, Sturgeon C.
   Surgery. 2018 Jun 11. pii: S0039-6060(18)30213-7. doi: 10.1016/j.surg.2018.04.036. [Epub ahead of print]

3. Telomerase reverse transcriptase induced thyroid carcinoma cell proliferation through PTEN/AKT signaling pathway.
   Zhang H, Hu N.
   Mol Med Rep. 2018 Jun 1. doi: 10.3892/mmr.2018.9119. [Epub ahead of print]

4. NRG1 regulates redox homeostasis via NRF2 in papillary thyroid cancer.
   Zhang TT, Qu N, Sun GH, Zhang L, Wang YJ, Mu XM, Wei WJ, Wang YL, Wang Y, Ji QH, Zhu YX, Shi RL.
   Int J Oncol. 2018 May 31. doi: 10.3892/ijo.2018.4426. [Epub ahead of print]

5. Appetite changes reveal depression subgroups with distinct endocrine, metabolic, and immune states.
   Simmons WK, Burrows K, Avery JA, Kerr KL, Taylor A, Bodurka J, Potter W, Teague TK, Drevets WC.
   Mol Psychiatry. 2018 Jun 13. doi: 10.1038/s41380-018-0093-6. [Epub ahead of print]

6. Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines.
   Albano D, Bertagna F, Bonacina M, Durmo R, Cerudelli E, Gazzilli M, Panarotto MB, Formenti AM, Mazziotti G, Giustina A, Giubbini R.
   Eur J Endocrinol. 2018 Jun 13. pii: EJE-18-0253. doi: 10.1530/EJE-18-0253. [Epub ahead of print]

7. Recent Topics Around Multiple Endocrine Neoplasia Type 1.
   Marx SJ.
   J Clin Endocrinol Metab. 2018 Apr 1;103(4):1296-1301. doi: 10.1210/jc.2017-02340.

8. Prognostic Evaluations Tailored to Specific Gastric Neuroendocrine Neoplasms: Analysis Of 200 Cases with Extended Follow-Up.
   Vanoli A, La Rosa S, Miceli E, Klersy C, Maragliano R, Capuano F, Persichella A, Martino M, Inzani F, Luinetti O, Di Sabatino A, Sessa F, Paulli M, Corazza GR, Rindi G, Bordi C, Capella C, Solcia E.
   Neuroendocrinology. 2018 Jun 12:1-13. doi: 10.1159/000489902. [Epub ahead of print]

9. Transcutaneously refillable, 3D-printed biopolymeric encapsulation system for the transplantation of endocrine cells.
   Farina M, Chua CYX, Ballerini A, Thekkedath U, Alexander JF, Rhudy JR, Torchio G, Fraga D, Pathak RR, Villanueva M, Shin CS, Niles JA, Sesana R, Demarchi D, Sikora AG, Acharya GS, Gaber AO, Nichols JE, Grattoni A.
   Biomaterials. 2018 May 30;177:125-138. doi: 10.1016/j.biomaterials.2018.05.047. [Epub ahead of print]

10. SLC12A7 alters adrenocortical carcinoma cell adhesion properties to promote an aggressive invasive behavior.
    Brown TC, Murtha TD, Rubinstein JC, Korah R, Carling T.
    Cell Commun Signal. 2018 Jun 8;16(1):27. doi: 10.1186/s12964-018-0243-0.

June 13, 2018

1. New Insights in Cushing Disease Treatment With Focus on a Derivative of Vitamin A.
   Fuertes M, Tkatch J, Rosmino J, Nieto L, Guitelman MA, Arzt E.
   Front Endocrinol (Lausanne). 2018 May 24;9:262. doi: 10.3389/fendo.2018.00262. eCollection 2018. Review.

2. Highly specific preoperative selection of solitary parathyroid adenoma cases in primary hyperparathyroidism by quantitative image analysis of the early-phase Technetium-99m sestamibi scan.
   Kim D, Rhodes JA, Hashim JA, Rickabaugh L, Brams DM, Pinkus E, Dou Y.
   J Med Imaging Radiat Oncol. 2018 Jun 7. doi: 10.1111/1754-9485.12753. [Epub ahead of print]

3. Surviving ectopic Cushing's syndrome: Quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up.
   Osswald A, Deutschbein T, Berr CM, Plomer E, Mickisch A, Ritzel K, Schopohl J, Beuschlein F, Fassnacht M, Hahner S, Reincke M.
   Eur J Endocrinol. 2018 Jun 6. pii: EJE-18-0212. doi: 10.1530/EJE-18-0212. [Epub ahead of print]

4. Adrenal Crises in Children: Perspectives and Research Directions.
   Rushworth RL, Torpy DJ, Stratakis CA, Falhammar H.
   Horm Res Paediatr. 2018 Jun 6:1-11. doi: 10.1159/000481660. [Epub ahead of print]

5. A rural perspective on minimally invasive parathyroidectomy: optimal preoperative imaging and patient outcomes.
   Binks M, Burrows D, Littlejohn D.
   ANZ J Surg. 2018 Jun 5. doi: 10.1111/ans.14374. [Epub ahead of print]

6. A case-control study of exposure to organophosphate flame retardants and risk of thyroid cancer in women.
   Deziel NC, Yi H, Stapleton HM, Huang H, Zhao N, Zhang Y.
   BMC Cancer. 2018 Jun 5;18(1):637. doi: 10.1186/s12885-018-4553-9.

7. Histology-proven recurrence in the lateral or central neck after systematic neck dissection for medullary thyroid cancer.
   Machens A, Lorenz K, Dralle H.
   Endocrine. 2018 Jun 5. doi: 10.1007/s12020-018-1625-1. [Epub ahead of print]

8. Current Knowledge on Endocrine Disrupting Chemicals (EDCs) from Animal Biology to Humans, from Pregnancy to Adulthood: Highlights from a National Italian Meeting.
   Street ME, Angelini S, Bernasconi S, Burgio E, Cassio A, Catellani C, Cirillo F, Deodati A, Fabbrizi E, Fanos V, Gargano G, Grossi E, Iughetti L, Lazzeroni P, Mantovani A, Migliore L, Palanza P, Panzica G, Papini AM, Parmigiani S, Predieri B, Sartori C, Tridenti G, Amarri S.
   Int J Mol Sci. 2018 Jun 2;19(6). pii: E1647. doi: 10.3390/ijms19061647. Review.

9. TERT promoter mutational screening as a tool to predict malignant behaviour in follicular thyroid tumours-three examples from the clinical routine.
   Hysek M, Paulsson JO, Wang N, Jatta K, Lindh C, Fuentes-Martinez N, Shabo I, Zedenius J, Juhlin CC.
   Virchows Arch. 2018 Jun 2. doi: 10.1007/s00428-018-2386-1. [Epub ahead of print]

10. Natural History of Contralateral Nodules After Lobectomy in Patients With Papillary Thyroid Carcinoma.
    Ritter A, Bachar G, Hirsch D, Benbassat C, Katz O, Kochen N, Diker-Cohen T, Akirov A, Shimon I, Robenshtok E.
    J Clin Endocrinol Metab. 2018 Feb 1;103(2):407-414. doi: 10.1210/jc.2017-01616.

June 6, 2018

1. Is serum TSH a biomarker of thyroid carcinoma in patients residing in a mildly iodine-deficient area?
   Swan KZ, Nielsen VE, Godballe C, Thrane JF, Mortensen MR, Schytte S, Pedersen HB, Christiansen P, Bonnema SJ. Endocrine. 2018 May 31. doi: 10.1007/s12020-018-1637-x. [Epub ahead of print]

2. Effectiveness of medical treatment for Cushing's syndrome: a systematic review and meta-analysis.
   Broersen LHA, Jha M, Biermasz NR, Pereira AM, Dekkers OM.
   Pituitary. 2018 May 31. doi: 10.1007/s11102-018-0897-z. [Epub ahead of print]

3. Comparing the safety of harmonic ACE and ACE+ around the recurrent laryngeal nerve in swine models.
   Kim HK, Chai YJ, Lee HY, Kim HY, Dionigi G.
   Ann Surg Treat Res. 2018 Jun;94(6):285-290. doi: 10.4174/astr.2018.94.6.285. Epub 2018 May 29.

4. The Outcome of Papillary Thyroid Cancer Associated with Graves' Disease: A Case Control Study.
   Menon R, Nair CG, Babu M, Jacob P, Krishna GP.
   J Thyroid Res. 2018 May 8;2018:8253094. doi: 10.1155/2018/8253094. eCollection 2018.

5. Molecular evaluation of a sporadic paraganglioma with concurrent IDH1 and ATRX mutations.
   Zhang J, Jiang J, Luo Y, Li X, Lu Z, Liu Y, Huang J, Hou Y, Pang Y, Sun MYF, Wang TS, Evans DB, Pacak K, Zhuang Z, Gao X. Endocrine. 2018 May 30. doi: 10.1007/s12020-018-1617-1. [Epub ahead of print]

6. Diabetes after pancreaticoduodenectomy: can we predict it?
   Singh AN, Pal S, Kilambi R, Madhusudhan KS, Dash NR, Tandon N, Sahni P.
   J Surg Res. 2018 Jul;227:211-219. doi: 10.1016/j.jss.2018.02.010. Epub 2018 Mar 20.

7. Functional adrenal cortex preservation: A good reason for posterior retroperitoneal endoscopic approach.
   Vidal Ó, Delgado-Oliver E, Díaz Del Gobbo R, Hanzu F, Squarcia M, Martínez D, Fuster D, Fondevila C.
   Cir Esp. 2018 May 24. pii: S0009-739X(18)30137-4. doi: 10.1016/j.ciresp.2018.04.008. [Epub ahead of print] English, Spanish

8. Decreasing Use of Radioactive Iodine for Low-Risk Thyroid Cancer in California, 1999 to 2015.
   Park KW, Wu JX, Du L, Leung AM, Yeh MW, Livhits MJ.
   J Clin Endocrinol Metab. 2018 Mar 1;103(3):1095-1101. doi: 10.1210/jc.2017-02269.

9. Typical carcinoid involving the main carina managed with arterial embolisation, endobronchial resection and ablation, ultimately followed by carinal resection.
   Tan MWY, Leong P, Antippa P, Jennings BR.
   BMJ Case Rep. 2017 Sep 28;2017. pii: bcr-2017-221800. doi: 10.1136/bcr-2017-221800.

10. Surgery Significantly Improves Neurocognition, Sleep, and Blood Pressure in Primary Hyperparathyroidism: A 3-Year Prospective Follow-Up Study.
    Storvall S, Ryhänen EM, Heiskanen I, Sintonen H, Roine RP, Schalin-Jäntti C.
    Horm Metab Res. 2017 Oct;49(10):772-777. doi: 10.1055/s-0043-118347. Epub 2017 Sep 18.

June 1, 2018

1. Transoral endoscopic thyroidectomy vestibular approach: a preliminary framework for assessment and safety.
   Russell J, Anuwong A, Dionigi G, Inabnet WB, Kim HY, Randolph GW, Richmon JD, Tufano RP.
   Thyroid. 2018 May 23. doi: 10.1089/thy.2017.0642. [Epub ahead of print]

2. Prophylactic Central Compartment Neck Dissection in Papillary Thyroid Cancer and Effect on Locoregional Recurrence.
   Hughes DT, Rosen JE, Evans DB, Grubbs E, Wang TS, Solórzano CC
   Ann Surg Oncol. 2018 May 21. doi: 10.1245/s10434-018-6528-0. [Epub ahead of print]

3. Genotypic characteristics and their association with phenotypic characteristics of hereditary medullary thyroid carcinoma in Korea.
   Jung KY, Kim SM, Kim MJ, Cho SW, Kim BW, Lee YS, Jeong JJ, Nam KH, Chung WY, Lee KE, Chung EJ, Kim HJ, Park DJ, Sung MW, Park CS, Cho BY, Park YJ, Chang HS.
   Surgery. 2018 May 17. pii: S0039-6060(18)30142-9. doi: 10.1016/j.surg.2018.03.018. [Epub ahead of print]

4. Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms.
   Stenman A, Zedenius J, Juhlin CC.
   Langenbecks Arch Surg. 2018 May 19. doi: 10.1007/s00423-018-1679-9. [Epub ahead of print]

5. Anaplastic thyroid cancer and hyperfractionated accelerated radiotherapy (HART) with and without surgery.
   Jacobsen AB, Grøholt KK, Lorntzsen B, Osnes TA, Falk RS, Sigstad E.
   Eur Arch Otorhinolaryngol. 2017 Dec;274(12):4203-4209. doi: 10.1007/s00405-017-4764-8. Epub 2017 Oct 10

6. Disease Severity at Presentation in Patients with Disease-Related Mortality from Differentiated Thyroid Cancer: Implications for the 2015 ATA Guidelines.
   Robenshtok E, Nachalon Y, Benbassat C, Hirsch D, Shimon I, Grossman A, Diker-Cohen T, Akirov A, Popovtzer A.Eur J Thyroid. 2017 Sep;27(9):1171-1176. doi: 10.1089/thy.2017.0040.

7. Thyrotropin Suppressive Therapy for Low-Risk Small Thyroid Cancer: A Propensity Score-Matched Cohort Study.
   Park S, Kim WG, Han M, Jeon MJ, Kwon H, Kim M, Sung TY, Kim TY, Kim WB, Hong SJ, Shong YK
   Thyroid. 2017 Sep;27(9):1164-1170. doi: 10.1089/thy.2017.0177. Epub 2017 Aug 8

8. Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.
   Ito Y, Onoda N, Ito KI, Sugitani I, Takahashi S, Yamaguchi I, Kabu K, Tsukada K.
   Thyroid. 2017 Sep;27(9):1142-1148. doi: 10.1089/thy.2016.0621. Epub 2017 Jul 24.

9. Imaging of Parathyroid Glands in End Stage Renal Disease.
   Sharma J, Halkar R, Weber CJ.
   Semin Dial. 2017 Jul;30(4):369-372. doi: 10.1111/sdi.12608. Epub 2017 May 30. Review.

10. Hyperkalemia in both surgically and medically treated patients with primary aldosteronism.
    Wada N, Shibayama Y, Umakoshi H, Ichijo T, Fujii Y, Kamemura K, Kai T, Sakamoto R, Ogo A, Matsuda Y, Fukuoka T, Tsuiki M, Suzuki T, Naruse M.
    J Hum Hypertens. 2017 Oct;31(10):627-632. doi: 10.1038/jhh.2017.38. Epub 2017 May 25.

May 24, 2018

1. Risk Factors for Central Neck Lymph Node Metastases in Follicular Variant vs. Classic Papillary Thyroid Carcinoma.
   Raffaelli M, De Crea C, Sessa L, Fadda G, Lombardi CP, Bellantone R.
   Endocrine. 2018 May 16. doi: 10.1007/s12020-018-1607-3. [Epub ahead of print]

2. Risk Factors Associated with Intrathyroid Extension of Thyroid Microcarcinomas.
   Slijepcevic N, Zivaljevic V, Diklic A, Jovanovic M, Oluic B, Paunovic I.
   Langenbecks Arch Surg. 2018 May 17. doi: 10.1007/s00423-018-1680-3. [Epub ahead of print]

3. Surgical Outcomes Following Repeat Transsphenoidal Surgery for Nonfunctional Pituitary Adenomas: A Retrospective Comparative Study.
   Bakhsheshian J, Wheeler S, Strickland BA, Pham MH, Rennert RC, Carmichael J, Weiss M, Zada G.
   Oper Neurosurg (Hagerstown). 2018 May 15. doi: 10.1093/ons/opy078. [Epub ahead of print]

4. Endoscopic vs. Microscopic Transsphenoidal Surgery for Cushing’s Disease: A Systematic Review and Meta-Analysis.
   Broersen LHA, Biermasz NR, van Furth WR, de Vries F, Verstegen MJT, Dekkers OM, Pereira AM.
   Pituitary. 2018 May 16. doi: 10.1007/s11102-018-0893-3. [Epub ahead of print]

5. C-Arm Compound Tomography- Assisted Venous Sampling Improved Right Adrenal Vein Cannulation and Sampling Quality in Primary Aldosteronism.
   Park CH, Hong N, Han K, Kang SW, Lee CR, Park S, Rhee Y.
   Endocrinol Metab (Seoul). 2018 May 4. [Epub ahead of print]

6. Management of Endocrine Disease: Which Metabolic Procedure? Comparing Outcomes in Sleeve Gastrectomy and Roux-en Y Gastric Bypass.
   Billeter AT, de la Garza Herrera J, Scheurlen KM, Nickel F, Billmann F, Müller-Stich B.
   Eur J Endocrinol. 2018 May 15. pii: EJE-18-0009. doi: 10.1530/EJE-18-0009. [Epub ahead of print]

7. Differential GIP/GLP-1 Intestinal Cell Distribution in Diabetics’ Yields Distinctive Rearrangements Depending on Roux-en-Y Biliopancreatic Limb Length.
   Palha AM, Pereira SS, Costa MM, Morais T, Maia AF, Guimarães M, Nora M, Monteiro MP.
   J Cell Biochem. 2018 May 15. doi: 10.1002/jcb.27062. [Epub ahead of print]

8. Co-Existence of <i>BRAF<sup>V600E</sup</i> and <i>TERT</i> Promoter Mutations in Papillary Thyroid Carcinoma is Associated with Tumor Aggressiveness, but not with Lymph Node Metastasis.
   Ren H, Shen Y, Hu D, He W, Zhou J, Cao Y, Mao Y, Dou Y, Xiong W, Xiao Q, Zhang Y, Su X.
   Cancer Manag Res. 2018 May 3;10:1005-1013. doi: 10.2147/CMAR.S159583. eCollection 2018.

9. Selective Parathyroid Venous Sampling in Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis.
   Ibraheem K, Toraih EA, Haddad AB, Farag M, Randolph GW, Kandil E.
   Laryngoscope. 2018 May 14. doi: 10.1002/lary.27213. [Epub ahead of print] Review.

10. Early Outcomes in Transoral Vestibular Thyroidectomy: Robotic Versus Endoscopic Techniques.
    Razavi CR, Khadem MGA, Fondong A, Clark JH, Richmon JD, Tufano RP, Russell JO.
    Head Neck. 2018 May 13. doi: 10.1002/hed.25323. [Epub ahead of print]

April 30, 2018

1. Endocrine Surgery in the Geriatric Population. McIntire JB, McCammon S, Mong ER.  Otolaryngol Clin North Am. 2018 Apr 23. pii: S0030-6665(18)30052-5. 

2. American Thyroid Association Guidelines and Statements: Past, Present, and Future. Sawka AM, Carty SE, Haugen BR, Hennessey JV, Kopp PA, Pearce EN, Sosa JA, Tufano RP, Jonklaas J. Thyroid. 2018 Apr 26. doi: 10.1089/thy.2018.0070. [Epub ahead of print]

3. Laparoscopic versus robotic adrenalectomy: a review of the national inpatient sample. Samreen S, Fluck M, Hunsinger M, Wild J, Shabahang M, Blansfield JA. J Robot Surg. 2018 Apr 25. doi: 10.1007/s11701-018-0808-3. 

4. Patient Frailty Should Be Used to Individualize Treatment Decisions in Primary Hyperparathyroidism. Seib CD, Chomsky-Higgins K, Gosnell JE, Shen WT, Suh I, Duh QY, Finlayson E. World J Surg. 2018 Apr 25. doi: 10.1007/s00268-018-4629-3. 

5. Predictive Factors of Secondary Normocalcemic Hyperparathyroidism after Roux-en-Y Gastric Bypass. Casella C, Molfino S, Mittempergher F, Cappelli C, Portolani N. Int J Endocrinol. 2018 Mar 6;2018:5010287. doi: 10.1155/2018/5010287. eCollection 2018.

6. Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of 18F-Fluorocholine PET/CT. Grimaldi S, Young J, Kamenicky P, Hartl D, Terroir M, Leboulleux S, Berdelou A, Hadoux J, Hescot S, Remy H, Baudin E, Schlumberger M, Deandreis D. Eur J Nucl Med Mol Imaging. 2018 Apr 22. doi: 10.1007/s00259-018-4018-z. [Epub ahead of print]

7. Adrenocorticotropic Hormone Secreting Pheochromocytoma Underlying Glucocorticoid Induced Pheochromocytoma Crisis. Geva GA, Gross DJ, Mazeh H, Atlan K, Ben-Dov IZ, Fischer M. Case Rep Endocrinol. 2018 Feb 20;2018:3963274. doi: 10.1155/2018/3963274. eCollection 2018.

8. Prognostic significance of gross extrathyroidal extension invading only strap muscles in differentiated thyroid carcinoma. Park SY, Kim HI, Kim JH, Kim JS, Oh YL, Kim SW, Chung JH, Jang HW, Kim TH. Br J Surg. 2018 Apr 17. doi: 10.1002/bjs.10830. [Epub ahead of print]

9. Prophylactic thyroidectomy in children with multiple endocrine neoplasia type 2. Prete FP, Abdel-Aziz T, Morkane C, Brain C, Kurzawinski TR; MEN2 in Children UK Collaborative Group. Br J Surg. 2018 Apr 17. doi: 10.1002/bjs.10856. [Epub ahead of print]

10. Quality of life in thyroid cancer-assessment of physician perceptions. James BC, Aschebrook-Kilfoy B, White MG, Applewhite MK, Kaplan SP, Angelos P, Kaplan EL, Grogan RH. J Surg Res. 2018 Jun;226:94-99. doi: 10.1016/j.jss.2017.11.069. Epub 2018 Feb 15.